• Participants with a past or resolved HBV infection, defined as having a negative HBsAg test and a positive total hepatitis B core antibody (HBcAb) test at screening, are eligible for the study if active HBV infection is ruled out on the basis of HBV ribonucleic acid (RNA)/deoxyribonucleic acid (DNA) viral load per local guidelines.